MZM2511

MZM2511 | Joined since 2020-07-26

Investing Experience Intermediate
Risk Profile Moderate

Followers

1

Following

0

Blog Posts

3

Threads

4,533

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
4,533
Past 30 days
20
Past 7 days
6
Today
0

User Comments
Stock

2020-12-11 21:26 | Report Abuse

@Singapore88. Not seen yet.....
Maybe the forces of buyer comes from the retail investors + small sharks/bankers. If there is a big investor, they will hold 5% or more shareholding, therefore will be announced at BURSA as a substantial share holder.

Stock

2020-12-11 20:18 | Report Abuse

Good day for today, Nexgram. Looking for better days next week.
Nexgram BOLEHH..

Stock

2020-12-11 11:22 | Report Abuse

At least the JV news attract some attention and the incoming progress concerning it if any can spur more attraction and will give more investors confidence on the coy.

Stock

2020-12-11 11:21 | Report Abuse

Just expecting a little improvement.

Stock

2020-12-11 11:20 | Report Abuse

For medium term or long term investors, the 1st QR is coming at the end of this month...

Stock

2020-12-11 10:06 | Report Abuse

@OKU_2020. Investors in cautious trade. Scare....

Stock

2020-12-11 06:06 | Report Abuse

Attackkkkkkkkk.
Nexgram, THE NEW GEM IN HEALTHCARE BUSINESSES AND VACCINE PRODUCER AND VACCINE DISRIBUTOR TO BE...

Covid-19 VACCINE to manufacture and distribute (JV with Rafarma)
and,
Covid-19 Test Kits (agreement with MKN/MOH and MTC)
Covid-19 Test (via subsidiary in Indonesia)
Tracvirus with tracking vaccination is ready (contract with MOH)
Tracvirus SafeTravelPass (contract with MOH)
Medical gloves and PPE (gown) (contract with MAPU in Indonesia)
NexgramBottleVaccine (via subsidiary operation)

Stock

2020-12-11 06:03 | Report Abuse

@frankietan.

frankietan The directors disposed milion of shares be careful .
-------------------------------------------
Is this "THE DIRECTOR' as you said?? Its the substantial share holder Ozura.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3112947

....... I think you better study who is Ozura, the one you said as the directors.

They are former creditor who being alloted ICPS as a settlement for their money owed by Nexgram. OZURA has no intention to be insider (long term investor) as their representative even not be elected as Board of Directors. If they want, they actually can join BOD because their shareholding is more than 10%.

Stock

2020-12-11 00:14 | Report Abuse

Nexgram, THE NEW GEM IN HEALTHCARE BUSINESSES AND VACCINE PRODUCER AND VACCINE DISRIBUTOR TO BE...

Covid-19 VACCINE to manufacture and distribute (JV with Rafarma)
and,
Covid-19 Test Kits (agreement with MKN/MOH and MTC)
Covid-19 Test (via subsidiary in Indonesia)
Tracvirus with tracking vaccination is ready (contract with MOH)
Tracvirus SafeTravelPass (contract with MOH)
Medical gloves and PPE (gown) (contract with MAPU in Indonesia)
NexgramBottleVaccine (via subsidiary operation)

Stock

2020-12-10 23:18 | Report Abuse

NEXGRAM HOLDINGS BERHAD ("NEXGRAM" OR "COMPANY")
MASTER STRATEGIC JOINT VENTURE AGREEMENT BETWEEN VACCINES LAB SDN BHD ("VACCINESLAB"), A WHOLLY OWNED SUBSIDIARY OF NEXGRAM WITH RAFARMA PHARMACEUTICALS INC. ("RAFARMA") ("PARTIES")

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3112948

Stock

2020-12-10 22:25 | Report Abuse

@JK22 Only in Malaysia or it did happen in the rest of the world . Few cents company get into vaccine development and cheap to attract punter to frying up the stock
---------------------------------------------------------------
The answer #3:

THAT’S WHY THE VACCINELAB – RAFARMA JV CHOOSES INDONESIA AS A HUB FOR VACCINE PRODUCTION:

https://www.gmanetwork.com/news/news/world/765519/asean-should-lead-in-mass-production-of-covid-19-vaccine-says-adb-specialist/story/

https://www.hindustantimes.com/world-news/indonesia-has-strongest-capacity-for-vaccine-production-in-se-asia-china/story-kzO75A7SAUWmNRG46Yq1mJ.html

https://www.freemalaysiatoday.com/category/world/2020/10/11/china-backs-indonesia-to-become-vaccine-hub-of-southeast-asia/

Stock

2020-12-10 22:24 | Report Abuse

@JK22 Only in Malaysia or it did happen in the rest of the world . Few cents company get into vaccine development and cheap to attract punter to frying up the stock
---------------------------------------------------------------
The answer #2:

------Vaccine Lab is included in the deal because via Nexgram Biomedic Sdn Bhd's subsidiary PT NDS Gobal Utama, Nexgram has been explored some Covid-19 businesses in Indonesia. With a number of contracts and as a distributor. Nexgram also has some contacts in Indonesia for sure. Therefore their joint venture firms are keen on Nexgram.

Stock

2020-12-10 22:23 | Report Abuse

@JK22 Only in Malaysia or it did happen in the rest of the world . Few cents company get into vaccine development and cheap to attract punter to frying up the stock
---------------------------------------------------------------
The answer:

JOINT VENTURE BETWEEN VACCINE LAB (s/o NEXGRAM) WITH RAFARMA (US company)
(To open a vaccine facility in Indonesia to research, develop, conduct clinical trials and license for various in-demand vaccines including Covid-19)

R. & D. Biocogency Laboratories Inc (Cyprus)
(parent company of RAFARMA)
I
RAFARMA (US) ------------------------------- JV Vaccines Lab (sub of NEXGRAM)
I
PJSC Kraspharma(sub of RAFARMA) (Russia)


THE JOINT VENTURE AGREEMENT TERMS:

----- RAFARMA plan includes the investment of approximately USD1,000,000,000 (US Dollar One Billion) for the joint venture.

----- VACCINESLAB will provide government joint venture, partnership, regulation, licenses, and incentives for the project

----- The production capacity of the plant is designed for 500-600 million doses, covering the needs of the entire territory of Indonesia and the ASEAN countries

Stock

2020-12-10 20:36 | Report Abuse

SEMUT YANG BANYAK NANTI BOLEH MENGALAHKAN GAJAH. He He

Stock

2020-12-10 19:54 | Report Abuse

@SlayerZ. Hopefully

Stock

2020-12-10 19:49 | Report Abuse

A POSSIBILITY:

Vaccine Lab + Rafarma Pharmaceuticals (US) + R. & D. Biocogency Laboratories Inc. (Cyprus) + subsidiary of Rafarma, PJSC Kraspharma (Russia) ———-> Russian or other source country Covid-19 vaccine ———> Indonesia and the ASEAN countries

Stock

2020-12-10 14:00 | Report Abuse

@intel.. Tak ada yang mustahil dalam saham. GETS GLOBAL BERHAD dari 4.5 sen pada 23 Mac 2020 boleh mencecah setinggi RM3.97.
Lebih dekat lagi dengan Nexgram (ready to be vaccine counter) ialah saham HWGB (disebabkan covid-19 vaksin) dari harga terendah 6 sen mencapai harga tertinggi RM1.03.
Betullah kedua-duanya saham spekulatif....

Stock

2020-12-10 11:07 | Report Abuse

Oww. Their NOSH ist it?

Stock

2020-12-10 10:50 | Report Abuse

@kenie. I didn't get your point. Share consolidation? How

Stock

2020-12-10 09:52 | Report Abuse

Russia belum mendapat pengiktirafan untuk penerimaan Sputnik V Vaccine dia di ASEAN kecuali di Filipina. Di Asia lainnya, India dan terima.
Melalui anak syarikat Nexgram, Vaccinelab mungkin diguna sebagai mediator untuk dapatkan peluang ini di Indonesia dan ASEAN
...... The Russian government had sent a letter to the Indonesia’s Health Ministry in September over the possibility of Sputnik V vaccine distribution, procurement and clinical trials. Preliminary results on the vaccine, which is currently in phase-three clinical trials, show its efficacy rate at 92 per cent, according to its developer, Gamaleya Research Institute.

Stock

2020-12-10 09:49 | Report Abuse

Rafarma Merger Company Bebig Approved For Production And Sale Of Yttrium-90 For Treatment Of Inoperable Liver Cancer .... received an updated RUSSIAN registration certificate for the production and sale of nanostructured microspheres based on yttrium-90 https://finance.yahoo.com/news/rafarma-merger-company-bebig-approved-141500701.html CONNECTION RAFARMA WITH THE RUSSIAN ???????

Stock

2020-12-10 09:48 | Report Abuse

He He. OKU_2020. The GHOST.

Stock

2020-12-09 21:23 | Report Abuse

RATIONALE AND UTILISATION OF PROCEEDS
The proceeds from the Disposal will be used to repay bank overdraft and for working capital if
deemed fit.

Stock

2020-12-09 21:13 | Report Abuse

Oh ya. Mana DRwarrant ni. Tak meriah tanpa dia. He He

Stock

2020-12-09 20:29 | Report Abuse

Go Go Nexgram... Ini kalilahhhh...

Stock

2020-12-09 19:09 | Report Abuse

KAG Group recording a loss of RM585,000

Stock

2020-12-09 18:53 | Report Abuse

@jennyhee. it's not site but to add on telegram group discussion at (NXGRAM CLUB)

Stock

2020-12-09 18:16 | Report Abuse

Still work for and wait for the announcement about vaccine deal at BURSA......

Stock

2020-12-09 18:13 | Report Abuse

@OKU_2220. Thank you for your support. He He.

Stock

2020-12-09 15:19 | Report Abuse

@OKU_2020. If someone lost his credibility, he will keep barking like a do g....

Stock

2020-12-09 09:20 | Report Abuse

Sabar... Tak nak geram dengan OKU_2020 al-penipu lagi. Nasib baik ada kawan-kawan counsel. Biar dia tetap tunggu @3 sen.

Stock

2020-12-09 06:45 | Report Abuse

Go Go Nexgram....
SafetTavelPass of Nexgram is already in service.

COVID-19 Screening Tests and Quarantine Charges for Traveller Coming Into Malaysia
TracVirus SafeTravelPass is a COVID-19 screening and accommodation arrangement service with the approval of Majilis Keselamatan Negara (MKN). This service is open to both Malaysians and non-Malaysians, and aims to provide a fast, safe, and seamless process for travellers coming into Malaysia.
https://safetravelpass.tracvirus.com.my/

Stock

2020-12-08 18:26 | Report Abuse

Please come to join our telegram forum discussion group, more articles, graph, news in our group to be shared. Only at 《NXGRAM CLUB》.. Thank you.

Stock

2020-12-08 14:46 | Report Abuse

@jennyhee. It's possible. Okay. What ever.

Stock

2020-12-08 14:07 | Report Abuse

@jennyhee. Then what are your theory??

Stock

2020-12-08 13:35 | Report Abuse

@jennyhee. OKU_2020 ia a naysayer/hater of Nexgram. He continuously condemned Nexgram whether the Nexgram's price was in uptrend or downtrend.
I don't think he has been starked in this counter because if he starked in this counter he should not condemned it while the price is on uptrend.
Maybe he want to press down the price so that he can get the share at cheaper price. He usually targeted @3 sen to buy.

Stock

2020-12-08 13:22 | Report Abuse

@jennyhee. Sorry. kena geram balik.
----------------------------------------------
Awak TOTALLY PENIPU, OKU_2020. What say you????

OKU_2020. Beri pendapat berbeza tak salah OKU wei. Beri pendapat yang surely tak betul adalah kerja ORANG BERNIAT JAHAT. OKU, awak memang nak jadi JAHAT KAN...

+++++++++++++++++++++

YOOOOOOOO....!

what do you expect from this Cap Ayam - Holland GN 3 ( PN 17 ) Nexgram.....
-------------------------------------------

Apakah ini fakta. Awak TOTALLY PENIPU.

------------------------------------------
Not listed as GN3 yet. Given RELIEF for a year. The condition will be reasses after a year period. Means not necessarily be listed as GN3 if Nexgram can settle all the problem arised based on the required clasification of GN3 listed issuer within the given relief year period.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3099172

......Nexgram will not be classified as a GN3 listed issuer and will not be required to comply with the obligations pursuant to Rule 8.04 and GN3 of the ACE LR for a period of 12 months from the date of this announcement. Nexgram will re-assess its condition and announce whether it continues to trigger any of the criteria in GN3 of the ACE LR upon the expiry of the 12 months from the date of this announcement.

Stock

2020-12-08 09:33 | Report Abuse

Tak nak geram dengan OKU_2020 al-penipu lagi. Nasib baik ada kawan-kawan counsel. Biar dia tetap tunggu @3 sen. He He He.

Stock

2020-12-08 08:13 | Report Abuse

Nexgram, THE NEW GEM IN HEALTHCARE BUSINESSES AND VACCINE PRODUCER AND VACCINE DISRIBUTOR TO BE... UP.. UP... NEXGRAM
.....................
Covid-19 VACCINE to manufacture and distribute (JV with Rafarma)
and,
Covid-19 Test Kits (agreement with MKN/MOH and MTC)
Covid-19 Test (via subsidiary in Indonesia)
Tracvirus with tracking vaccination is ready (contract with MOH)
Tracvirus SafeTravelPass (contract with MOH)
Medical gloves and PPE (gown) (contract with MAPU in Indonesia)
NexgramBottleVaccine (via subsidiary operation)

Stock

2020-12-08 08:12 | Report Abuse

8dragon. Nexgram are trying to cater the vaccine businesses for Indonesian and ASEAN market. It should be a greater deal.

Stock

2020-12-07 21:15 | Report Abuse

Tak nak geram dengan OKU_2020 al-penipu lagi. Nasib baik ada kawan-kawan counsel. Biar dia tetap tunggu @3 sen. He He He.

Stock

2020-12-07 18:38 | Report Abuse

@MadCow75. Aiyahhh. Dah naik kan. Slow Slow Slow. Kemudian sampai masanya BOOOOMM. He He

Stock

2020-12-07 14:58 | Report Abuse

Then it's not wise for you to keep barking here just to make a funny story.

Stock

2020-12-07 14:16 | Report Abuse

Tak nak geram dengan OKU_2020 lagi. Nasib baik ada kawan-kawan counsel. Biar dia tetap tunggu @3 sen. He He He.

Stock

2020-12-07 11:26 | Report Abuse

Tak nak geram dengan OKU_2020 lagi. Nasib baik ada kawan-kawan counsel. Biar dia tetap tunggu @3 sen. He He He.
Tapi nana Drwarrant ni??

Stock

2020-12-07 10:53 | Report Abuse

Belum. Agak banyak lagi tu

Stock

2020-12-07 10:24 | Report Abuse

Where is Drwarrant. We missed you. Attaccccccck.

Stock

2020-12-07 09:15 | Report Abuse

Wow....... Belum check lagi tapai. Baru suam suam

Stock

2020-12-07 07:39 | Report Abuse

Nexgram, THE NEW GEM IN HEALTHCARE BUSINESSES AND VACCINE PRODUCER AND VACCINE DISRIBUTOR TO BE... UP.. UP... NEXGRAM
........................
Covid-19 VACCINE to manufacture and distribute (JV with Rafarma)
and,
Covid-19 Test Kits (agreement with MKN/MOH and MTC)
Covid-19 Test (via subsidiary in Indonesia)
Tracvirus with tracking vaccination is ready (contract with MOH)
Tracvirus SafeTravelPass (contract with MOH)
Medical gloves and PPE (gown) (contract with MAPU in Indonesia)
NexgramBottleVaccine (via subsidiary operation)